BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 34842030)

  • 1. Palmitoylethanolamide: A Potential Alternative to Cannabidiol.
    Clayton P; Subah S; Venkatesh R; Hill M; Bogoda N
    J Diet Suppl; 2023; 20(3):505-530. PubMed ID: 34842030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoids and Sleep: Exploring Biological Mechanisms and Therapeutic Potentials.
    D'Angelo M; Steardo L
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabis for the Treatment of Epilepsy: an Update.
    Gaston TE; Szaflarski JP
    Curr Neurol Neurosci Rep; 2018 Sep; 18(11):73. PubMed ID: 30194563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoids as Immune System Modulators: Cannabidiol Potential Therapeutic Approaches and Limitations.
    Aziz AI; Nguyen LC; Oumeslakht L; Bensussan A; Ben Mkaddem S
    Cannabis Cannabinoid Res; 2023 Apr; 8(2):254-269. PubMed ID: 36413346
    [No Abstract]   [Full Text] [Related]  

  • 5. Cannabis and the exocannabinoid and endocannabinoid systems. Their use and controversies.
    Millán-Guerrero RO; Isais-Millán S
    Gac Med Mex; 2019; 155(5):471-474. PubMed ID: 32091020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phytocannabinoids: Exploring Pharmacological Profiles and Their Impact on Therapeutical Use.
    Blebea NM; Pricopie AI; Vlad RA; Hancu G
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naturally Occurring Cannabinoids and their Role in Modulation of Cardiovascular Health.
    Karimian Azari E; Kerrigan A; O'Connor A
    J Diet Suppl; 2020; 17(5):625-650. PubMed ID: 32677481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid-Based Therapies and Brain Development: Potential Harmful Effect of Early Modulation of the Endocannabinoid System.
    Schonhofen P; Bristot IJ; Crippa JA; Hallak JEC; Zuardi AW; Parsons RB; Klamt F
    CNS Drugs; 2018 Aug; 32(8):697-712. PubMed ID: 30109642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Status and Prospects for Cannabidiol Preparations as New Therapeutic Agents.
    Fasinu PS; Phillips S; ElSohly MA; Walker LA
    Pharmacotherapy; 2016 Jul; 36(7):781-96. PubMed ID: 27285147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropharmacological Effects of the Main Phytocannabinoids: A Narrative Review.
    Dos Santos RG; Hallak JEC; Crippa JAS
    Adv Exp Med Biol; 2021; 1264():29-45. PubMed ID: 33332002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD).
    Peng J; Fan M; An C; Ni F; Huang W; Luo J
    Basic Clin Pharmacol Toxicol; 2022 Apr; 130(4):439-456. PubMed ID: 35083862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabis y los sistemas exocannabinoide y endocannabinoide. Su uso y controversias.
    Millán-Guerrero RO; Isais-Millán S
    Gac Med Mex; 2019; 155(5):508-512. PubMed ID: 31695229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phytocannabinoids: Useful Drugs for the Treatment of Obesity? Special Focus on Cannabidiol.
    Bielawiec P; Harasim-Symbor E; Chabowski A
    Front Endocrinol (Lausanne); 2020; 11():114. PubMed ID: 32194509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can cannabidiol have an analgesic effect?
    Kulesza B; Mazurek M; Kurzepa J
    Fundam Clin Pharmacol; 2024 Feb; 38(1):33-41. PubMed ID: 37584368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.
    Devinsky O; Cilio MR; Cross H; Fernandez-Ruiz J; French J; Hill C; Katz R; Di Marzo V; Jutras-Aswad D; Notcutt WG; Martinez-Orgado J; Robson PJ; Rohrback BG; Thiele E; Whalley B; Friedman D
    Epilepsia; 2014 Jun; 55(6):791-802. PubMed ID: 24854329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phytocannabinoid Pharmacology: Medicinal Properties of
    Sampson PB
    J Nat Prod; 2021 Jan; 84(1):142-160. PubMed ID: 33356248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Targets of Cannabidiol in Neurological Disorders.
    Ibeas Bih C; Chen T; Nunn AV; Bazelot M; Dallas M; Whalley BJ
    Neurotherapeutics; 2015 Oct; 12(4):699-730. PubMed ID: 26264914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Considerations and Implications of Cannabidiol Use During Pregnancy.
    Sarrafpour S; Urits I; Powell J; Nguyen D; Callan J; Orhurhu V; Simopoulos T; Viswanath O; Kaye AD; Kaye RJ; Cornett EM; Yazdi C
    Curr Pain Headache Rep; 2020 Jun; 24(7):38. PubMed ID: 32524214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ
    Boggs DL; Nguyen JD; Morgenson D; Taffe MA; Ranganathan M
    Neuropsychopharmacology; 2018 Jan; 43(1):142-154. PubMed ID: 28875990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabidiol or CBD Oil: Help, Hope, and Hype for Psychiatric and Neurologic Conditions.
    Newton M; Newton DW
    J Am Psychiatr Nurses Assoc; 2020; 26(5):447-457. PubMed ID: 32508204
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.